GEHC · US market
GE HealthCare Technologies Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$29.10bnFinancials dated 31 March 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$1.91bn
- Latest-quarter run-rate earnings
- US$1.56bn
- Latest fiscal-year earnings
- US$2.08bn
- Trailing revenue
- US$20.98bn
- Latest-quarter run-rate revenue
- US$20.52bn
- Latest fiscal-year revenue
- US$20.63bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- CSD · Invesco S&P Spin-Off ETF8.81% weight · Holdings dated 19 August 2026
- IHI · iShares U.S. Medical Devices ETF4.59% weight · Holdings dated 19 August 2026
- HEAL · Global X HealthTech ETF4.17% weight · Holdings dated 31 May 2026
- MVAL · VanEck Morningstar Wide Moat Value ETF3.56% weight · Holdings dated 30 June 2026
- HWCAX · Hotchkis & Wiley Disciplined Value Fund Class A2.54% weight · Holdings dated 30 June 2026
- MWMZX · VanEck Morningstar Wide Moat Fund Class Z2.21% weight · Holdings dated 30 June 2026
- MOAT · VanEck Morningstar Wide Moat ETF2.21% weight · Holdings dated 30 June 2026
- OAKM · Oakmark U.S. Large Cap ETF1.96% weight · Holdings dated 30 June 2026
- QQXT · First Trust NASDAQ-100 Ex-Technology Sector Index Fund1.91% weight · Holdings dated 30 June 2026
- MDEV · First Trust Indxx Medical Devices ETF1.80% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 March 2026. Informational research, not investment advice.